In this episode of the Psychedelic Spotlight Podcast, we delve deep into PSYC's latest developments and future directions. CEO David Flores shares an in-depth update, shedding light on the company’s strategic milestones and the broader impact on the psychedelic sector.
Matthew Dunehoo and David delve into an enlightening discussion about the hurdles, victories, and breakthroughs propelling PSYC ahead. They explore how Psychedelic Spotlight is adapting to changes and what these developments signify for stakeholders and the broader community, reaffirming their dedication to advancing psychedelic medicine.